Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Eleonora Salamon"'
Autor:
Irene Avagnina, Anna Santini, Irene Maghini, Eleonora Salamon, Simonetta Papa, Luca Giacomelli, Giorgio Perilongo, Caterina Agosto, Franca Benini
Publikováno v:
BMC Palliative Care, Vol 22, Iss 1, Pp 1-7 (2023)
Abstract Background There has been a growing interest in studying the value of physical exercise in children with disabilities or chronic health conditions because of evidence of improvement in quality of life, social acceptance, and physical functio
Externí odkaz:
https://doaj.org/article/46ca67f1af6c4273b026e5fd1b5bc351
Autor:
Caterina Agosto, Eleonora Salamon, Antuan Divisic, Francesca Benedetti, Luca Giacomelli, Aashni Shah, Giorgio Perilongo, Franca Benini
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-4 (2021)
Abstract Background We report the clinical outcomes observed in our patients with SMA type 1 or 2 receiving nusinersen, and we comment on the ethical implications of this treatment, in line with our results and those reported by Audic et al. in their
Externí odkaz:
https://doaj.org/article/9967417211454b4497ece127bb57bdff
Autor:
Caterina Agosto, Eleonora Salamon, Luca Giacomelli, Simonetta Papa, Francesca Benedetti, Franca Benini
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Nusinersen is the first oligonucleotide-based drug that is approved for the treatment of spinal muscular atrophy. In January 2020, the WHO declared COVID-19 a pandemic and nusinersen-provider centers had to postpone planned infusions for some childre
Externí odkaz:
https://doaj.org/article/c42ce51835864b87b04736dd1ed7d58b
Autor:
Caterina Agosto, Francesca Benedetti, Eleonora Salamon, Anna Mercante, Simonetta Papa, Luca Giacomelli, Anna Santini, Franca Benini
Publikováno v:
Acta Paediatrica. 112:311-312
Autor:
Eleonora Salamon, Simonetta Papa, Caterina Agosto, Franca Benini, Francesca Benedetti, Luca Giacomelli
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 12 (2021)
Frontiers in Neurology, Vol 12 (2021)
Nusinersen is the first oligonucleotide-based drug that is approved for the treatment of spinal muscular atrophy. In January 2020, the WHO declared COVID-19 a pandemic and nusinersen-provider centers had to postpone planned infusions for some childre
Autor:
Francesca Benedetti, Caterina Agosto, Luca Giacomelli, Franca Benini, Eleonora Salamon, Giorgio Perilongo, Antuan Divisic, Aashni Shah
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-4 (2021)
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-4 (2021)
Background We report the clinical outcomes observed in our patients with SMA type 1 or 2 receiving nusinersen, and we comment on the ethical implications of this treatment, in line with our results and those reported by Audic et al. in their analysis
Publikováno v:
Acta Paediatrica
Publikováno v:
Journal of Paediatrics and Child Health. 56:995-996
Autor:
Eleonora Salamon, Chiara Di Pede, Matteo Motta, Adriano Ferrari, Franca Benini, Caterina Agosto
Background Respiratory muscle weakness associated with scoliosis in type-2 spinal muscular atrophy (SMA) leads to respiratory impairment. Spinal brace, generally utilized to slow scoliosis progression and support sitting, could worsen lung function a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6aab06f91855d3b7e87021fa00b826
https://hdl.handle.net/11380/1169101
https://hdl.handle.net/11380/1169101
Autor:
Paolo Fidelbo, Rosalia Ragusa, Carmelo Viscosi, Andrea Benedetto, Eleonora Salamone, Angelo Pisano, Margherita Ferrante
Publikováno v:
Medical Sciences Forum, Vol 19, Iss 1, p 12 (2023)
Since 2020, the Catania-Messina-Enna Cancer Registry (CR) has operated a transformational and incremental program while also applying a Lean Six Sigma methodology (LSS) to optimize the processes and reduce waste. Each project aimed to raise the perfo
Externí odkaz:
https://doaj.org/article/c7785849cb0349469ffd80d98ddb5936